PharmaVision's Emerging Technologies & Research reports provide detailed analysis of recent technological advances that may impact the discovery, development, delivery, diagnosis and treatment of disease encompassing bioinformatics, biomarkers, high throughput screening, in silico modelling, in vivo animal modelling, microfluidics, nanotechnology, systems biology and translational medicine. It also includes recent scientific advances in antisense, epigenetics, gene therapy and RNA interference and cell and tissue regeneration that may revolutionise the development of future treatments.
DMNOV 1111
DMBIOMAR 1111
DM HGS 1111
DM IMG 0611
DM CellT 0611
ESP GL BIO 01/11
ESP CV BIO 08/08
ESP CNS BIO 08/08
ESP CAN BIO 08/08